Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients

OKYO Short Information OKYO Pharma Limited


home / stock / okyo / okyo short

OKYO OKYO Quote OKYO Short OKYO News OKYO Articles OKYO Message Board

Short Information | OKYO Pharma Limited (NASDAQ:OKYO)

Twenty Trading Day Totals
Total Shorted Volume 825,486
Total Actual Volume 3,228,179
Short Trends
Cover Days 16
Short Days 0
No Change Days 4
Averages
Average Short Volume 41,274
Average Short Percentage 26.53%

Is there a OKYO Short Squeeze or Breakout about to happen?

See the OKYO Short Analysis for free Sign up or Login

Powered by Squeeze Report

OKYO Twenty Trading Day's Volume to Short Volume Chart

OKYO Twenty Trading Day Price Chart

OKYO Short Data Results Days

DateOpen Close HighLowTotal VolumeShort VolumeShort Percentage
07-11-2025$2.95$2.81$2.96$2.6981,85210,79313.19%
07-10-2025$2.99$2.86$3$2.8239,1503,3348.52%
07-09-2025$2.9$2.92$3.1$2.89181,81133,62818.5%
07-08-2025$2.81$2.89$2.89$2.8120,1264,83324.01%
07-07-2025$2.88$2.82$2.92$2.7882,73033,86340.93%
07-03-2025$2.9$2.78$2.9$2.6981,43222,67027.84%
07-02-2025$2.66$2.91$2.92$2.6272,08230,67042.55%
07-01-2025$2.52$2.61$2.66$2.4747,61714,96131.42%
06-30-2025$2.49$2.57$2.57$2.4354,34318,29033.66%
06-27-2025$2.41$2.45$2.46$2.4140,5218,38520.69%
06-26-2025$2.49$2.425$2.49$2.370150,0077,07314.14%
06-25-2025$2.35$2.47$2.48$2.298666,09926,67140.35%
06-24-2025$2.18$2.3$2.3486$2.1838,0417,35419.33%
06-23-2025$2.27$2.19$2.37$2.05185,43547,05325.37%
06-20-2025$2.46$2.37$2.56$2.25812,214155,31219.12%
06-18-2025$2.15$2.25$2.44$2.1289,99831,93335.48%
06-17-2025$2.57$2.21$2.634$2.1332202,54750,71125.04%
06-16-2025$3.1$2.56$3.11$2.5316,70692,47229.2%
06-13-2025$2.43$3.01$3.02$2.37264,26091,13434.49%
06-12-2025$2.45$2.53$2.58$2.33501,208134,34626.8%
Stock Information

Get OKYO Alerts

News, Short Squeeze, Breakout and More Instantly...

OKYO Pharma Limited Company Name:

OKYO Stock Symbol:

NASDAQ Market:

-3.15% G/L:

$2.81 Last:

81,852 Volume:

$2.95 Open:

$2.81 Close:

OKYO Pharma Limited Website:

OKYO Pharma Limited Logo

Ad

Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients
RECENT OKYO NEWS
  • OKYO - Goldman Small Cap Research Issues New Research Update on OKYO Pharma Limited

    Raising Price Target Due to Fundamental Drivers BALTIMORE, MD / ACCESS Newswire / June 11, 2025 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new research update on OKYO Pharma Limite...

  • OKYO - OKYO Pharma to Present at the Bio International Convention

    LONDON and NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO ), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA approved therapy, and for inflammatory...

  • OKYO - OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit

    LONDON and NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA approved therapy, and for inflammatory eye d...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Important Investor News Alert (NASDAQ: CVKD)

 Logo

  • CVKD - Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients

    LVAD patients face a high risk of bleeding events associated with oral anticoagulation alongside increased risk of cardiovascular (CV) events such as stroke Hospitalization costs for patients following a major bleeding event associated with oral anticoagulation use averages $39,000 per ev...

Link your X Account

Link your X Account to Market Wire News

When you linking your X Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

Be alerted of any news about your stocks and see what other stocks are trending.



Connect with Us

Join our Telegram Alerts Channel

Telegram

Join our Discord

Discord

Get OKYO Alerts

Get OKYO Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.


Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2025 Market Wire News 1